BSH statement on the MHRA approval of the use of gene editing therapy in sickle cell disease and transfusion-dependent thalassaemia
There is a paucity of available effective treatments for sickle cell disease and thalassaemia both of which lead to...
5 months ago
BSH is sponsoring two places for BSH members on the Fellowship in Clinical AI.
The Fellowship in Clinical AI is a year-long programme that is integrated part-time alongside training or employment. Our fellows are smart and energetic individuals...
5 months ago
